1. Home
  2. ONMD vs PASG Comparison

ONMD vs PASG Comparison

Compare ONMD & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$0.71

Market Cap

34.7M

Sector

N/A

ML Signal

N/A

PASG

Passage Bio Inc.

N/A

Current Price

$8.58

Market Cap

28.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
PASG
Founded
2006
2017
Country
United States
United States
Employees
22
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
28.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ONMD
PASG
Price
$0.71
$8.58
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$23.50
AVG Volume (30 Days)
10.3M
28.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.28
52 Week High
$4.22
$20.00

Technical Indicators

Market Signals
Indicator
ONMD
PASG
Relative Strength Index (RSI) 47.91 43.38
Support Level $0.60 $8.10
Resistance Level $0.91 $8.85
Average True Range (ATR) 0.11 0.73
MACD 0.01 0.11
Stochastic Oscillator 14.91 43.43

Price Performance

Historical Comparison
ONMD
PASG

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: